Affiliation:
1. Chitkara College of Pharmacy, Chitkara University, Punjab, India
2. Faculty of Pharmacy, Philadelphia University, Philadelphia, Jordan
3. Faculty of Medicine, The University of Queensland, Queensland, Australia
Abstract
Background:
An endo-β-glucuronidase enzyme, Heparanase (HPSE), degrades the side chains of
polymeric heparan sulfate (HS), a glycosaminoglycan formed by alternate repetitive units of D-glucosamine
and D-glucuronic acid/L-iduronic acid. HS is a major component of the extracellular matrix and basement
membranes and has been implicated in processes of the tissue’s integrity and functional state. The degradation
of HS by HPSE enzyme leads to conditions like inflammation, angiogenesis, and metastasis. An elevated HPSE
expression with a poor prognosis and its multiple roles in tumor growth and metastasis has attracted significant
interest for its inhibition as a potential anti-neoplastic target.
Methods:
We reviewed the literature from journal publication websites and electronic databases such as Bentham,
Science Direct, PubMed, Scopus, USFDA, etc., about HPSE, its structure, functions, and role in cancer.
Results:
The present review is focused on Heparanase inhibitors (HPIns) that have been isolated from natural
resources or chemically synthesized as new therapeutics for metastatic tumors and chronic inflammatory diseases
in recent years. The recent developments made in the HPSE structure and function are also discussed,
which can lead to the future design of HPIns with more potency and specificity for the target.
Conclusion:
HPIns can be a better target to be explored against various cancers.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献